US FDA approves Amgen's Uplizna to treat IgG4─related disease
Amgen announced that the US Food and Drug Administration (FDA) has approved Uplizna as the first and only treatment for adults living with Immunoglobulin G4-related disease (IgG4-RD). IgG4-RD is a chronic and debilitating immune-mediated inflammatory …